Resources

Psychedelics Report covers science, not treatment sales. These resources can help you check claims, understand research participation, and distinguish different United States regulatory pathways. Information is educational and does not replace individualized medical advice. Research papers below are background evidence, not announcements of later approvals or trial results.

Understand the science

The National Institute on Drug Abuse explains psychedelic and dissociative drugs, their health effects, and current research questions. Its overview is a useful starting point before reading headlines about psilocybin, LSD, MDMA, or ketamine. Different substances have different mechanisms and risks; evidence for one does not establish benefit for another.

Explore clinical research

ClinicalTrials.gov's study guide explains research terminology and participation. Study listings can identify sponsors, eligibility criteria, locations, and contacts. Registration is not government endorsement, and recruitment information should be confirmed directly. The National Institute of Mental Health participant guide describes informed consent, volunteering, questions to ask, and the difference between research and ordinary care.

Check regulatory claims

The FDA's psychedelic investigation guidance explains considerations for drug development. Guidance is not product approval. The January 2025 Spravato label documents esketamine's indications and monitoring requirements. Ketamine's psychiatric use is off-label; compounded ketamine is not FDA-approved. Review the FDA compounding alerts for relevant warnings.

Understand state services

The Oregon Health Authority access guide explains licensed psilocybin services, screening, preparation, and transportation planning. State service authorization is separate from federal prescription-drug approval. Check the responsible agency in your jurisdiction rather than assuming another state's rules apply.

Protect your health

Do not stop prescribed medicines to pursue psychedelics without consulting your clinician. Ask any provider about credentials, consent, emergency arrangements, costs, and follow-up. In the United States, call or text 988 for crisis support; call 911 for immediate danger or a medical emergency. Psychedelics Report does not provide crisis care or individual treatment recommendations.